# Stromal Vascular Fraction for Treatment of Xerostomia

> **NCT03061110** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Midwestern Regional Medical Center**

## Conditions studied

- Xerostomia Due to Radiotherapy (Disorder)

## Interventions

- **BIOLOGICAL:** Stromal Vascular Fraction
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT03061110
- **Lead sponsor:** Midwestern Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11-01
- **Primary completion:** 2020-12-28
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Internal funding not awarded.
- **Last updated:** 2018-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03061110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03061110, "Stromal Vascular Fraction for Treatment of Xerostomia". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03061110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*